Top Canadian Cannabis Producers Caught In International Controversy Over Imports

A group of Canadian cannabis producers found themselves in hot water after the commissioner of Israel’s Trade Levies Unit launched an “anti-dumping” investigation related to the import of medical cannabis from Canada, as reported by Marijuana Business Daily’s Matt Lamers.

Danny Tal, director of import administration at Israel’s Ministry of Economy and Industry, said in a letter addressed to Michael Mancini, chief commercial counselor for the Embassy of Canada in Israel, that he has found a connection between these imports and damaging effects on Israel’s domestic cannabis industry.

“I wish to inform you that after I found that special circumstances exist, I have decided to initiate an Anti-Dumping investigation concerning the importation of medical cannabis from Canada,” Tal said. “Our findings, regarding whether there is dumping, consequent injury and the duty required, will be determined on the basis of best information available.”

The investigation was initiated following reports from Israeli companies that allegedly face financial losses due to competition with low-priced Canadian imports, wrote Israeli Cannabis Magazine. According to data from Health Canada, …

Full story available on Benzinga.com